Protalix BioTherapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2013 | $-30.7M | $-32.5M | $1.9M | $4.1M |
| FY2014 | $-29.3M | $-30.1M | $785.0K | $1.2M |
| FY2015 | $-24.3M | $-24.7M | $464.0K | $1.8M |
| FY2016 | $-32.1M | $-32.9M | $849.0K | $988.0K |
| FY2017 | $-10.0M | $-11.0M | $971.0K | $337.0K |